Medical Care

Global Myasthenia Gravis Therapies Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Myasthenia Gravis Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Myasthenia Gravis Therapies.
The Myasthenia Gravis Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Myasthenia Gravis Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Myasthenia Gravis Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alexion Pharmaceuticals
Novartis
CSL Behring
Grifols
Segment by Type
Ocular Myasthenia Gravis
Congenital Myasthenia Gravis
Generalized Myasthenia Gravis
Transient Myasthenia Gravis
Others
Segment by Application
Hospitals and Clinics
Diagnostic Centers
Academic and Research Organizations
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Myasthenia Gravis Therapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myasthenia Gravis Therapies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Ocular Myasthenia Gravis
1.2.3 Congenital Myasthenia Gravis
1.2.4 Generalized Myasthenia Gravis
1.2.5 Transient Myasthenia Gravis
1.2.6 Others
1.3 Market by Application
1.3.1 Global Myasthenia Gravis Therapies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Academic and Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Myasthenia Gravis Therapies Market Perspective (2020-2031)
2.2 Global Myasthenia Gravis Therapies Growth Trends by Region
2.2.1 Global Myasthenia Gravis Therapies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Myasthenia Gravis Therapies Historic Market Size by Region (2020-2025)
2.2.3 Myasthenia Gravis Therapies Forecasted Market Size by Region (2026-2031)
2.3 Myasthenia Gravis Therapies Market Dynamics
2.3.1 Myasthenia Gravis Therapies Industry Trends
2.3.2 Myasthenia Gravis Therapies Market Drivers
2.3.3 Myasthenia Gravis Therapies Market Challenges
2.3.4 Myasthenia Gravis Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Myasthenia Gravis Therapies Players by Revenue
3.1.1 Global Top Myasthenia Gravis Therapies Players by Revenue (2020-2025)
3.1.2 Global Myasthenia Gravis Therapies Revenue Market Share by Players (2020-2025)
3.2 Global Myasthenia Gravis Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Myasthenia Gravis Therapies Revenue
3.4 Global Myasthenia Gravis Therapies Market Concentration Ratio
3.4.1 Global Myasthenia Gravis Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis Therapies Revenue in 2024
3.5 Global Key Players of Myasthenia Gravis Therapies Head office and Area Served
3.6 Global Key Players of Myasthenia Gravis Therapies, Product and Application
3.7 Global Key Players of Myasthenia Gravis Therapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Myasthenia Gravis Therapies Breakdown Data by Type
4.1 Global Myasthenia Gravis Therapies Historic Market Size by Type (2020-2025)
4.2 Global Myasthenia Gravis Therapies Forecasted Market Size by Type (2026-2031)
5 Myasthenia Gravis Therapies Breakdown Data by Application
5.1 Global Myasthenia Gravis Therapies Historic Market Size by Application (2020-2025)
5.2 Global Myasthenia Gravis Therapies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Myasthenia Gravis Therapies Market Size (2020-2031)
6.2 North America Myasthenia Gravis Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Myasthenia Gravis Therapies Market Size by Country (2020-2025)
6.4 North America Myasthenia Gravis Therapies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Myasthenia Gravis Therapies Market Size (2020-2031)
7.2 Europe Myasthenia Gravis Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Myasthenia Gravis Therapies Market Size by Country (2020-2025)
7.4 Europe Myasthenia Gravis Therapies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Myasthenia Gravis Therapies Market Size (2020-2031)
8.2 Asia-Pacific Myasthenia Gravis Therapies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Myasthenia Gravis Therapies Market Size by Region (2020-2025)
8.4 Asia-Pacific Myasthenia Gravis Therapies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Myasthenia Gravis Therapies Market Size (2020-2031)
9.2 Latin America Myasthenia Gravis Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Myasthenia Gravis Therapies Market Size by Country (2020-2025)
9.4 Latin America Myasthenia Gravis Therapies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Myasthenia Gravis Therapies Market Size (2020-2031)
10.2 Middle East & Africa Myasthenia Gravis Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Myasthenia Gravis Therapies Market Size by Country (2020-2025)
10.4 Middle East & Africa Myasthenia Gravis Therapies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alexion Pharmaceuticals
11.1.1 Alexion Pharmaceuticals Company Details
11.1.2 Alexion Pharmaceuticals Business Overview
11.1.3 Alexion Pharmaceuticals Myasthenia Gravis Therapies Introduction
11.1.4 Alexion Pharmaceuticals Revenue in Myasthenia Gravis Therapies Business (2020-2025)
11.1.5 Alexion Pharmaceuticals Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Myasthenia Gravis Therapies Introduction
11.2.4 Novartis Revenue in Myasthenia Gravis Therapies Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 CSL Behring
11.3.1 CSL Behring Company Details
11.3.2 CSL Behring Business Overview
11.3.3 CSL Behring Myasthenia Gravis Therapies Introduction
11.3.4 CSL Behring Revenue in Myasthenia Gravis Therapies Business (2020-2025)
11.3.5 CSL Behring Recent Development
11.4 Grifols
11.4.1 Grifols Company Details
11.4.2 Grifols Business Overview
11.4.3 Grifols Myasthenia Gravis Therapies Introduction
11.4.4 Grifols Revenue in Myasthenia Gravis Therapies Business (2020-2025)
11.4.5 Grifols Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Myasthenia Gravis Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Ocular Myasthenia Gravis
Table 3. Key Players of Congenital Myasthenia Gravis
Table 4. Key Players of Generalized Myasthenia Gravis
Table 5. Key Players of Transient Myasthenia Gravis
Table 6. Key Players of Others
Table 7. Global Myasthenia Gravis Therapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Myasthenia Gravis Therapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Myasthenia Gravis Therapies Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Myasthenia Gravis Therapies Market Share by Region (2020-2025)
Table 11. Global Myasthenia Gravis Therapies Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Myasthenia Gravis Therapies Market Share by Region (2026-2031)
Table 13. Myasthenia Gravis Therapies Market Trends
Table 14. Myasthenia Gravis Therapies Market Drivers
Table 15. Myasthenia Gravis Therapies Market Challenges
Table 16. Myasthenia Gravis Therapies Market Restraints
Table 17. Global Myasthenia Gravis Therapies Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Myasthenia Gravis Therapies Market Share by Players (2020-2025)
Table 19. Global Top Myasthenia Gravis Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis Therapies as of 2024)
Table 20. Ranking of Global Top Myasthenia Gravis Therapies Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Myasthenia Gravis Therapies Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Myasthenia Gravis Therapies, Headquarters and Area Served
Table 23. Global Key Players of Myasthenia Gravis Therapies, Product and Application
Table 24. Global Key Players of Myasthenia Gravis Therapies, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Myasthenia Gravis Therapies Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Myasthenia Gravis Therapies Revenue Market Share by Type (2020-2025)
Table 28. Global Myasthenia Gravis Therapies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Myasthenia Gravis Therapies Revenue Market Share by Type (2026-2031)
Table 30. Global Myasthenia Gravis Therapies Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Myasthenia Gravis Therapies Revenue Market Share by Application (2020-2025)
Table 32. Global Myasthenia Gravis Therapies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Myasthenia Gravis Therapies Revenue Market Share by Application (2026-2031)
Table 34. North America Myasthenia Gravis Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Myasthenia Gravis Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Myasthenia Gravis Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Myasthenia Gravis Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Myasthenia Gravis Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Myasthenia Gravis Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Myasthenia Gravis Therapies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Myasthenia Gravis Therapies Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Myasthenia Gravis Therapies Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Myasthenia Gravis Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Myasthenia Gravis Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Myasthenia Gravis Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Myasthenia Gravis Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Myasthenia Gravis Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Myasthenia Gravis Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 49. Alexion Pharmaceuticals Company Details
Table 50. Alexion Pharmaceuticals Business Overview
Table 51. Alexion Pharmaceuticals Myasthenia Gravis Therapies Product
Table 52. Alexion Pharmaceuticals Revenue in Myasthenia Gravis Therapies Business (2020-2025) & (US$ Million)
Table 53. Alexion Pharmaceuticals Recent Development
Table 54. Novartis Company Details
Table 55. Novartis Business Overview
Table 56. Novartis Myasthenia Gravis Therapies Product
Table 57. Novartis Revenue in Myasthenia Gravis Therapies Business (2020-2025) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. CSL Behring Company Details
Table 60. CSL Behring Business Overview
Table 61. CSL Behring Myasthenia Gravis Therapies Product
Table 62. CSL Behring Revenue in Myasthenia Gravis Therapies Business (2020-2025) & (US$ Million)
Table 63. CSL Behring Recent Development
Table 64. Grifols Company Details
Table 65. Grifols Business Overview
Table 66. Grifols Myasthenia Gravis Therapies Product
Table 67. Grifols Revenue in Myasthenia Gravis Therapies Business (2020-2025) & (US$ Million)
Table 68. Grifols Recent Development
Table 69. Research Programs/Design for This Report
Table 70. Key Data Information from Secondary Sources
Table 71. Key Data Information from Primary Sources
Table 72. Authors List of This Report


List of Figures
Figure 1. Myasthenia Gravis Therapies Picture
Figure 2. Global Myasthenia Gravis Therapies Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Myasthenia Gravis Therapies Market Share by Type: 2024 VS 2031
Figure 4. Ocular Myasthenia Gravis Features
Figure 5. Congenital Myasthenia Gravis Features
Figure 6. Generalized Myasthenia Gravis Features
Figure 7. Transient Myasthenia Gravis Features
Figure 8. Others Features
Figure 9. Global Myasthenia Gravis Therapies Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Myasthenia Gravis Therapies Market Share by Application: 2024 VS 2031
Figure 11. Hospitals and Clinics Case Studies
Figure 12. Diagnostic Centers Case Studies
Figure 13. Academic and Research Organizations Case Studies
Figure 14. Myasthenia Gravis Therapies Report Years Considered
Figure 15. Global Myasthenia Gravis Therapies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Myasthenia Gravis Therapies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Myasthenia Gravis Therapies Market Share by Region: 2024 VS 2031
Figure 18. Global Myasthenia Gravis Therapies Market Share by Players in 2024
Figure 19. Global Top Myasthenia Gravis Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis Therapies as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Myasthenia Gravis Therapies Revenue in 2024
Figure 21. North America Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Myasthenia Gravis Therapies Market Share by Country (2020-2031)
Figure 23. United States Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Myasthenia Gravis Therapies Market Share by Country (2020-2031)
Figure 27. Germany Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Myasthenia Gravis Therapies Market Share by Region (2020-2031)
Figure 35. China Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Myasthenia Gravis Therapies Market Share by Country (2020-2031)
Figure 43. Mexico Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Myasthenia Gravis Therapies Market Share by Country (2020-2031)
Figure 47. Turkey Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Myasthenia Gravis Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Alexion Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis Therapies Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Myasthenia Gravis Therapies Business (2020-2025)
Figure 52. CSL Behring Revenue Growth Rate in Myasthenia Gravis Therapies Business (2020-2025)
Figure 53. Grifols Revenue Growth Rate in Myasthenia Gravis Therapies Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies